These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 9790340)

  • 41. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic head adenocarcinoma. An update meta-analysis.
    Wang W; He Y; Wu L; Ye L; Yao L; Tang Z
    Pancreatology; 2019 Dec; 19(8):1074-1080. PubMed ID: 31668841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of extended lymphadenectomy in the treatment of pancreatic head adenocarcinoma: review and meta-analysis.
    Svoronos C; Tsoulfas G; Katsourakis A; Noussios G; Chatzitheoklitos E; Marakis NG
    ANZ J Surg; 2014 Oct; 84(10):706-11. PubMed ID: 24165093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
    Tol JA; Gouma DJ; Bassi C; Dervenis C; Montorsi M; Adham M; Andrén-Sandberg A; Asbun HJ; Bockhorn M; Büchler MW; Conlon KC; Fernández-Cruz L; Fingerhut A; Friess H; Hartwig W; Izbicki JR; Lillemoe KD; Milicevic MN; Neoptolemos JP; Shrikhande SV; Vollmer CM; Yeo CJ; Charnley RM;
    Surgery; 2014 Sep; 156(3):591-600. PubMed ID: 25061003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Tanizawa Y
    Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.
    Stojadinovic A; Brooks A; Hoos A; Jaques DP; Conlon KC; Brennan MF
    J Am Coll Surg; 2003 Jun; 196(6):954-64. PubMed ID: 12788434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
    Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
    Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.
    Zacharias T; Jaeck D; Oussoultzoglou E; Neuville A; Bachellier P
    J Gastrointest Surg; 2007 Mar; 11(3):350-6. PubMed ID: 17458610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
    Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.
    Malleo G; Maggino L; Capelli P; Gulino F; Segattini S; Scarpa A; Bassi C; Butturini G; Salvia R
    J Am Coll Surg; 2015 Aug; 221(2):367-79.e4. PubMed ID: 26081176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extended resection for pancreatic adenocarcinoma.
    Reddy SK; Tyler DS; Pappas TN; Clary BM
    Oncologist; 2007 Jun; 12(6):654-63. PubMed ID: 17602057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
    Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
    J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dose "extended" surgery for pancreatic head adenocarcinoma have survival impact?].
    Nagino M; Nimura Y
    Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):173-6. PubMed ID: 16878409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Patients with non-advanced pancreatic cancer benefit from extended lymphadenectomy].
    Popiela T; Kedra B; Sierzega M; Kubisz A
    Zentralbl Chir; 2002 Nov; 127(11):960-4. PubMed ID: 12476369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robotic Lymphadenectomy During Pancreatoduodenectomy with First Superior Mesenteric Artery Dissection.
    Memeo R; De Blasi V; Perotto O; Mutter D; Marescaux J; Pessaux P
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):968. PubMed ID: 27459980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current opinion on lymphadenectomy in pancreatic cancer surgery.
    Pavlidis TE; Pavlidis ET; Sakantamis AK
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):21-5. PubMed ID: 21269930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of a pylorus-preserving pancreatoduodenectomy for pancreatic cancer: a comparison with results of the Whipple procedure.
    Takada T; Yasuda H; Amano H; Yoshida M; Ando H
    Hepatogastroenterology; 1997; 44(18):1536-40. PubMed ID: 9427018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.
    Yoshida T; Matsumoto T; Sasaki A; Morii Y; Aramaki M; Kitano S
    Arch Surg; 2002 Jan; 137(1):69-73. PubMed ID: 11772220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan.
    Mukaiya M; Hirata K; Satoh T; Kimura M; Yamashiro K; Ura H; Oikawa I; Denno R
    World J Surg; 1998 Mar; 22(3):248-52; discussion 252-3. PubMed ID: 9494416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.